#
Rescula Ophthalmic Solution
  • Professionals
  • FDA PI

Rescula Ophthalmic Solution

Generic name:unoprostone isopropyl
Dosage form: ophthalmic solution
Drug class:Ophthalmic glaucoma agents

Medically reviewed by Drugs.com. Last updated on Dec 22, 2021.

Indications and Usage for Rescula Ophthalmic Solution

Rescula (unoprostone isopropyl ophthalmic solution) 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Rescula Ophthalmic Solution Dosage and Administration

The recommended dosage is one drop in the affected eye(s) twice daily.

Rescula may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If two drugs are used, they should be administered at least five (5) minutes apart[see Patient Counseling Information (17.5)].

Dosage Forms and Strengths

Unoprostone isopropyl ophthalmic solution, 1.5 mg/mL.

Contraindications

Rescula is contraindicated in patients with hypersensitivity to unoprostone isopropyl or any other ingredient in this product.

Warnings and Precautions

Iris Pigmentation

Unoprostone isopropyl ophthalmic solution may gradually increase the pigmentation of the iris. The pigmentation change is believed to be due to increased melanin content in the melanocytes rather than to an increase in the number of melanocytes. The long term effects of increased pigmentation are not known. Iris color changes seen with administration of unoprostone isopropyl ophthalmic solution may not be noticeable for several months to years. Typically, the brown pigmentation around the pupil spreads concentrically towards the periphery of the iris and the entire iris or parts of the iris become more brownish. Neither nevi nor freckles of the iris appear to be affect...